AdRegeneer was founded in 2019 with the mission to revolutionize regenerative medicine for the nervous system. The company focuses on filling a critical gap in modern healthcare by developing groundbreaking therapies that promote axonal regrowth and remyelination, processes essential for nerve repair. Through its innovative research and scientific approach, AdRegeneer is committed to advancing next-generation regenerative treatments that restore neural function and improve patients’ quality of life.